Recipharm Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recipharm ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recipharm Ltd Today - Breaking & Trending Today

Acerus Reports Fourth Quarter and Full Year 2020 Financial Results


Share:
TORONTO, March 11, 2021 (GLOBE NEWSWIRE) Acerus Pharmaceuticals Corporation ( Acerus or the Company ) (TSX:ASP, OTCQB:ASPCF) today reported its financial results for the three and twelve-month period ended December 31, 2020. Unless otherwise noted, all amounts are in US dollars and are prepared in accordance with International Financial Reporting Standards ( IFRS ).
Recent Highlights
Significant growth in US NATESTO® total prescriptions during the fourth quarter of 2020 – driven by the specialist (urologist and endocrinologist) segment
Rights offering completed in November 2020, strengthening the balance sheet
Shipments of NATESTO® to South Korea and Taiwan resumed in the fourth quarter
The Company entered into an agreement with Torreya Partners LLC to identify strategic options for product acquisition and growth capital ....

United States , South Korea , United Kingdom , Chris Witty , Ed Gudaitis , Health Canada Approval Status , Torreya Partners , Acerus Pharmaceuticals Corporation , Company Contact , Metuchen Pharmaceuticals , Syneos Health Inc , Recipharm Ltd , International Council For Harmonization , International Financial Reporting Standards , Women Health , Company Urivarx , Syneos Health , Health Canada , Pharmaceuticals Corporation , Chief Executive Officer , North America , Three Months Ended December , North American , Year Ended December , Health Canada Approval , New Drug Submission ,